Novum Pharmaceutical Research Services

Executive Summary

Novum Pharmaceutical Research Services (Novum PRS) is a full-service global Contract Research Organization (CRO) that provides end-to-end clinical research services from early-phase (Phase I) through late-phase (Phase II-IV) development, along with bioanalytical services and scientific affairs. Founded in 2005 and headquartered in Pittsburgh, the company operates in the USA, Canada, and Spain, enabling it to manage complex, multi-regional studies across numerous therapeutic areas and dosage forms. As a private company, Novum PRS competes in the highly fragmented CRO market by offering comprehensive capabilities tailored to biotech and pharmaceutical clients seeking flexible and efficient clinical development partnerships.

Upcoming Catalysts (preview)

• Q3 2026Major Contract Award from Top-20 Pharma65% success
• Q1 2027Expansion of Bioanalytical Laboratory Capacity80% success
• TBDStrategic Partnership for Late-Phase Trial Management50% success